Evidence map›Paper›PMID 31334030›Full record

ArticleIntegrative medicine research2019

Ezarul Faradianna Lokman, Fatin Saparuddin, Hussin Muhammad, Maizatul Hasyima Omar, Azlina Zulkapli

Open access · goldAbstract read
In one paragraph

Article in Integrative medicine research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. A Systematic Review ofMolecules (Basel, Switzerland) · 2022
    Pooled it
  2. Review
  3. Kidney tea [Frontiers in pharmacology · 2024
    Article
  4. The standardizedHeliyon · 2023
    Article
  5. Pharmaceuticals (Basel, Switzerland) · 2023
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ezarul Faradianna LokmanEndocrine and Metabolic Unit, Nutrition, Metabolism and Cardiovascular Research Centre (NMCRC), Malaysia.
Fatin SaparuddinEndocrine and Metabolic Unit, Nutrition, Metabolism and Cardiovascular Research Centre (NMCRC), Malaysia.
Hussin MuhammadToxicology and Pharmacology Unit, Herbal Medicine Research Centre (HMRC), Malaysia.
Maizatul Hasyima OmarPhytochemistry Unit, Herbal Medicine Research Centre (HMRC), Malaysia.
Azlina ZulkapliLaboratory Animal Resource Unit, Medical Research Resource Centre (MRRC), Malaysia.
Ministry of Health · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMaternal hyperglycemia is associated with increased risk of adverse outcomes for both mother and offspring. Insulin is the standard treatment of hyperglycemia with the aim to reduce risks of complications, however, due to several restrictions, the search for more effective drugs from traditional medicinal plants continues.

methodsThe antidiabetic effects of

resultsOral glucose tolerance test indicated that treatment with

conclusion

Indexed as

AntidiabeticGestational diabetes mellitusOrthosiphon stamineus

Identifiers

PMID31334030
PMCPMC6624239
OpenAlexW2948553931

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.